[Funding alert] French Milktech Startup Numi Secures €3 Million in Seed Funding
Nov 10, 2023 | By Oliver Bennett

Numi, a French milktech firm, secures €3 million in seed money. A variety of investors, including Heartcore Capital, HCVC, Financière Saint James Kima Ventures, and Kost Capital, provide the seed money.
With over 100 bioactive compounds, the company wants to produce an item that is as near to "real" breast milk as possible. Eden Banon-Lagrange said that the cash will help the business with recruitment and speeding up research and development.
Read also - London-based Letoon Holding Secures £20M in Funding
Numerous entrepreneurs have entered this field of bioscience, which is gaining popularity. US companies BioMilq (funded by Bill Gate), Helaina, and TurtleTree in Singapore belong to those in this arena.
RECOMMENDED FOR YOU
[Funding alert] Dublin-based Marama Labs Secures €1.5M in Seed Plus Funding
Oliver Bennett
Jan 23, 2024
[Funding alert] Delft-based AgriData Innovations Secures Undisclosed Funding
Oliver Bennett
Feb 19, 2024
Icecat acquisition news – Amsterdam-based Icecat has Acquired Decodata
Kailee Rainse
Nov 6, 2024
Read also - Copenhagen-based Biotech Startup Octarine Bio Secures €4.35 Million in Funding
The company gets mammary cells by means of partnerships with lactariums and hospitals. To begin producing milk, the cells are then cultured under carefully monitored conditions using an array of laboratory procedures. After being extracted, the milk is purified.
About Numi
Numi, which was founded by Eden Banon-Lagrange and Eugénie Pezé-Heidsieck, aims to use cultured cells to replicate in vivo breast milk and provide parents with a natural option for circumstances where nursing is not feasible. Human breast cells are isolated, cultivated, and developed in a lab setting in order to make the milk.






